Singapore-Japan team finds common virus that triggers growth of nasopharyngeal cancer
Therapeutics | News | 1 Comment | 06 Jun, 2024
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...Read more
Evolving Market Dynamics in Biopharma and Genomic Medicines
Therapeutics | Opinion | By Hithaishi C Bhaskar | 1 Comment | 05 Jun, 2024
Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...Read more
Abu Dhabi government collaborates with Pfizer to advance research in sickle cell disease
Therapeutics | News | 0 Comment | 04 Jun, 2024
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...Read more
Singapore study reveals surprising twist in how diabetes drugs help the heart
Therapeutics | News | 0 Comment | 31 May, 2024
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...Read more
OBiO Tech launches Clinical Evaluation and Translation Centre for rare diseases in China
Therapeutics | News | 0 Comment | 30 May, 2024
OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...Read more
Evotec and CHDI Extend 20-Year Collaboration to Advance Huntington’s Disease Therapeutics
Therapeutics | News | 0 Comment | 30 May, 2024
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...Read more
Astatine to emerge as Japan-originated therapy for prostate cancer patients
Therapeutics | News | 0 Comment | 28 May, 2024
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...Read more
Singapore designs new genetic tool to investigate brain function and psychiatric disorders
Therapeutics | News | 0 Comment | 24 May, 2024
Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...Read more
Singapore opens doors for new developments in cancer biomarker discovery
Therapeutics | News | 1 Comment | 22 May, 2024
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...Read more
Traverse the rapid evolution of AI in combating the pediatric myopia epidemic in Asia
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 21 May, 2024
The urgency to address the myopia epidemic among children has never been more pressing. Recent studies reveal an al...Read more
Australia launches new specialist ophthalmic clinical trial facility
Therapeutics | News | 0 Comment | 21 May, 2024
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...Read more
Singapore's AI potential and prospects to emerge as a premier clinical trials hub
Therapeutics | Opinion | 0 Comment | 17 May, 2024
As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...Read more
Achieving optimal therapeutic modalities for NCDs in the APMA region
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 16 May, 2024
The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...Read more
Singapore approves J&J's Bispecific Antibody treatment for Multiple Myeloma
Therapeutics | News | 0 Comment | 15 May, 2024
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...Read more
Singapore unveils first public-private partnership center for speciality molecular testing
Therapeutics | Company results | By Hithaishi C Bhaskar | 1 Comment | 13 May, 2024
Singapore's National University Hospital (NUH) and leading RNA technology company, Mirxes have officialy unveiled the NU...Read more
Singapore suggests repurposing of existing cancer drugs to treat aggressive brain cancer
Therapeutics | News | 0 Comment | 13 May, 2024
Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five years. Th...Read more
New biotech research and manufacturing hub opens at University of Queensland, Australia
Therapeutics | News | 0 Comment | 10 May, 2024
A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The Universi...Read more
RBobay Pharma boosts CRDMO offerings with Cytiva's FlexFactory platform
Therapeutics | News | 0 Comment | 09 May, 2024
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDM...Read more